Re-assessing Evidence for Adverse Ocular Reactions Associated with Fluoroquinolones: Implications for Intracameral Use

Ocul Immunol Inflamm. 2022 Jan 2;30(1):208-209. doi: 10.1080/09273948.2020.1775857. Epub 2020 Aug 12.

Author

David M Hinkle¹

Affiliation

¹ Department of Ophthalmology and Visual Sciences, West Virginia University Eye Institute, Morgantown, West Virginia, USA.

PMID: 32783748
DOI: 10.1080/09273948.2020.1775857

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / adverse effects
Endophthalmitis* / drug therapy
Endophthalmitis* / etiology
Eye
Fluoroquinolones* / adverse effects
Humans
Moxifloxacin

Substances

Anti-Bacterial Agents
Fluoroquinolones
Moxifloxacin